BRIEF published on 08/27/2024 at 13:05, 7 months 14 days ago Pharnext begins liquidation proceedings Creditors Liquidation Paris Commercial Court Pharnext Suspension Of Listing
BRIEF published on 07/04/2024 at 20:05, 9 months 5 days ago Pharnext announces the termination of the financing contract granted by Néovacs Investors Termination Funding Pharnext Néovacs
BRIEF published on 06/18/2024 at 18:35, 9 months 22 days ago Pharnext announces the extension of the conciliation procedure until July 15, 2024 Pharnext Conciliation Procedure CMT1A PXT3003 Tasly
BRIEF published on 05/07/2024 at 19:15, 11 months 2 days ago Adjustment of the nominal value at Pharnext Biopharmaceutical Capital Reduction Pharnext Nominal Value Neurodegenerative Diseases
BRIEF published on 04/30/2024 at 23:50, 11 months 9 days ago Pharnext announces its 2023 results and the progress of its conciliation procedure 2023 Financial Results Pharnext Conciliation Procedure Phase III Clinical Trial Cost Control
PRESS RELEASE published on 01/04/2023 at 08:30, 2 years 3 months ago Pharnext strengthens its Senior Leadership Team with the appointment of Scott Johnson as VP, Head of Quality
Published on 04/10/2025 at 15:15, 3 hours 36 minutes ago ReelTime’s Reel Intelligence "RI" Outperforms AI While Requiring a Fraction of The Resources
Published on 04/10/2025 at 15:00, 3 hours 51 minutes ago Route1 Signs Significant New Orders with Major Cities in the Southwestern United States and Announces Key Corporate Updates Including Its Acquisition Growth Strategy
Published on 04/10/2025 at 15:00, 3 hours 51 minutes ago Inspire Veterinary Partners Announces Attendance at Upcoming Investor Events
Published on 04/10/2025 at 15:00, 3 hours 51 minutes ago Xebra Brands Launches National RFP to Establish Cannabis Cultivation Partnerships Across Mexico
Published on 04/10/2025 at 14:30, 4 hours 21 minutes ago CCL to Hold Live Webcast Call to Discuss 2025 First Quarter Results, Thursday, May 8, 2025, at 7:30 a.m. ET
Published on 04/10/2025 at 18:19, 31 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 04/10/2025 at 18:15, 36 minutes ago EQS-Adhoc: SCHOTT Pharma AG & Co. KGaA: SCHOTT Pharma: Preliminary Q2 2025 figures exceed capital market expectations
Published on 04/10/2025 at 18:12, 39 minutes ago Galenica Annual General Meeting approves all motions and elects new member of the Board of Directors
Published on 04/10/2025 at 18:01, 50 minutes ago Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 04/10/2025 at 17:45, 1 hour 6 minutes ago EURAZEO INVESTS IN EKOSCAN INTEGRITY, A LEADING GLOBAL PROVIDER OF ADVANCED NON-DESTRUCTIVE TESTING SOLUTIONS FOR CRITICAL INDUSTRIAL APPLICATIONS AND INFRASTRUCTURE
Published on 04/09/2025 at 18:59, 23 hours 51 minutes ago Description of the 2025-2026 Share Buyback Program
Published on 04/09/2025 at 18:57, 23 hours 53 minutes ago Minutes of the Combined General Meeting held on April 9, 2025
Published on 04/09/2025 at 17:45, 1 day 1 hour ago COGELEC : 2024 full-year results and Q1 2025 revenue.
